PULM — Pulmatrix, Inc.
$1.29
$-0.01 (-0.76%)
Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.
Market Cap
$4.71M
Forward P/E
-0.3x
52-Week Range
N/A
PULM Price History
Revenue vs. Net Income
$6.1M
Revenue · FY2022
Annual. Net margin is shown under each year.
Free Cash Flow
-$19.4M
FCF · FY2022
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
-52.7%
ROCE · FY2022
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
4.2x
Assets ÷ liabilities · FY2022
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
1.4%
CapEx · FY2022
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
3.4M
Diluted shares · FY2022
Only one year of share data is available, so no change can be shown yet.
